In May 2023, SuperLife celebrated a momentous achievement with the inauguration of our highly anticipated GMP (Good Manufacturing Practice) and HACCP (Hazard Analysis and Critical Control Points) manufacturing facility in Malaysia. This pivotal event signifies a paramount step forward in our organizational trajectory, one that expeditiously materialized in less than five years since SuperLife was founded.
This accomplishment profoundly reaffirms our unwavering dedication to the advancement of our R&D (Research & Development) capabilities. It is through this commitment that we meticulously design, create, and validate products with clinical rigor, aimed at enhancing the health and well-being of our customers and members.
The advent of this state-of-the-art manufacturing facility positions SuperLife on a higher echelon within the direct selling industry, aligning with our mission to offer tested and proven products that improve the well-being of our customers. A focal point of our ongoing effort revolves around pioneering the development of cutting-edge plant stem cell-based products and technologies.
Connect with us anytime.
